[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] SCHMIDT A,WEBER O F.In memoriam of Rudolf virchow:a historical retrospective including aspects of inflammation,infection and neoplasia[J].Contrib Microbiol,2006,13:1-15.
[3] CHEN L,KONG X,YAN C,et al.The research progress on the prognostic value of the common hematological parameters in peripheral venous blood in breast cancer[J].Onco Targets Ther,2020,13:1397-1412.
[4] HARA K,AOYAMA T,YAMADA T,et al.The prognostic value of the perioperative systemic inflammation score for patients with advanced gastric cancer[J].Anticancer Res,2020,40(3):1503-1512.
[5] GUO W,CAI S,ZHANG F,et al.Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer[J].Thorac Cancer,2019,10(4):761-768.
[6] OMICHI C,NAKAMURA K,HARAGA J,et al.Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer[J].Cancer Med,2016,5(6):1074-1080.
[7] IIDA H,TANI M,KOMEDA K,et al.Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma[J].HPB (Oxford),2022,24(1):101-115.
[8] ZHANG H,SHI J,XIE H,et al.Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer[J].Nutrition,2023,116:112191.
[9] HASKINS I N,BAGINSKY M,AMDUR R L,et al.Preoperative hypoalbuminemia is associated with worse outcomes in colon cancer patients[J].Clin Nutr,2017,36(5):1333-1338.
[10] IMAI D,MAEDA T,SHIMOKAWA M,et al.Prognostic nutritional index is superior as a predictor of prognosis among various inflammation-based prognostic scores in patients with hepatocellular carcinoma after curative resection[J].Hepatol Res,2020,50(1):101-109.
[11] STANTON S E,DISIS M L.Clinical significance of tumor-infiltrating lymphocytes in breast cancer[J].J Immunother Cancer,2016,4:59.
[12] SOLIS-CASTILLO L A,GARCIA-ROMO G S,DIAZ-RODRIGUEZ A,et al.Tumor-infiltrating regulatory T cells,CD8/Treg ratio,and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer[J].Breast Cancer,2020,27(5):837-849.
[13] QIANMEI Y,ZEHONG S,GUANG W,et al.Recent advances in the role of Th17/Treg cells in tumor immunity and tumor therapy[J].Immunol Res,2021,69(5):398-414.
[14] 汤忠祝，刘冠，郑晓，等.C反应蛋白、白蛋白、血红蛋白与老年局部晚期胰腺癌放化疗的相关性[J].中国老年学杂志，2014，34(19):5413-5414.
[15] 林鑫，翟泰宇，孙轶华.血清C-反应蛋白与血清白蛋白的比值与恶性肿瘤患者预后评估的关系[J].标记免疫分析与临床，2019，26(10):1778-1781.
[16] 王逸君，张碧云，陈乐君，等.炎症及营养指标与直肠癌新辅助放化疗病理反应及患者预后的相关性研究[J].东南大学学报(医学版)，2021，40(5):578-585.
[17] WU H,WANG M D,LIANG L,et al.Nanotechnology for hepatocellular carcinoma:from surveillance,diagnosis to management[J].Small,2021,17(6):e2005236.
[18] ZHENG W J,WANG P X,SUN Y F,et al.Uncovering the heterogeneity and clinical relevance of circulating tumor-initiating cells in hepatocellular carcinoma using an integrated immunomagnetic-microfluidic platform[J].ACS Appl Mater Interfaces,2022,14(32):36425-36437.
[19] MüLLER L,HAHN F,MAHRINGER-KUNZ A,et al.Immunonutritive scoring for patients with hepatocellular carcinoma undergoing transarterial chemoembolization:evaluation of the CALLY Index[J].Cancers (Basel),2021,13(19):5018.
[20] ETTINGER D S,AISNER D L,WOOD D E,et al.NCCN guidelines insights:non-small cell lung cancer,version 5.2018[J].J Natl Compr Canc Netw,2018,16(7):807-821.
[21] HERBST R S,MORGENSZTERN D,BOSHOFF C.The biology and management of non-small cell lung cancer[J].Nature,2018,553(7689):446-454.
[22] LIU X Y,ZHANG X,ZHANG Q,et al.The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer[J].Support Care Cancer,2023,31(9):533.
[23] 郑强，赵斌，杜鹏，等.全身免疫炎症指数与胃癌相关性的研究进展[J].现代医学，2022，50(11):1475-1481.
[24] DIGKLIA A,WAGNER A D.Advanced gastric cancer:Current treatment landscape and future perspectives[J].World J Gastroenterol,2016,22(8):2403-2414.
[25] CUNNINGHAM D,ALLUM W H,STENNING S P,et al.Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer[J].N Engl J Med,2006,355(1):11-20.
[26] SIEGEL R L,MILLER K D,WAGLE N S,et al.Cancer statistics,2023[J].CA Cancer J Clin,2023,73(1):17-48.
[27] KEUM N,GIOVANNUCCI E.Global burden of colorectal cancer:emerging trends,risk factors and prevention strategies[J].Nat Rev Gastroenterol Hepatol,2019,16(12):713-732.
[28] FELICIANO E M C,KROENKE C H,MEYERHARDT J A,et al.Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer:results from the C SCANS study[J].JAMA Oncol,2017,3(12):e172319.
[29] SCHMITT M,GRETEN F R.The inflammatory pathogenesis of colorectal cancer[J].Nat Rev Immunol,2021,21(10):653-667.
[30] YANG M,LIN S Q,LIU X Y,et al.Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer:From the investigation on nutrition status and clinical outcome of common cancers study[J].Front Immunol,2023,14:1131496.
[31] FURUKAWA K,TSUNEMATSU M,TANJI Y,et al.Impact of C-reactive protein-albumin-lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis[J].Surg Oncol,2023,47:101911.
[32] WANG W,GU J,LIU Y,et al.Pre-treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a prognostic biomarker of survival in patients with epithelial ovarian cancer[J].Cancer Manag Res,2022,14:2803-2812.
[33] TSAI Y T,KO C A,CHEN H C,et al.Prognostic value of CRP-Albumin-Lymphocyte (CALLY) index in patients undergoing surgery for oral cavity cancer[J].J Cancer,2022,13(10):3000-3012.
[34] TSUNEMATSU M,HARUKI K,TANIAI T,et al.The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy[J].Ann Gastroenterol Surg,2022,7(3):503-511. |
